Nanoparticles designed to harness transcytosis achieve deeper tumour penetration.
References
Minchinton, A. I. & Tannock, I. F. Nat. Rev. Cancer 6, 583–592 (2006).
Chauhan, V. P. & Jain, R. K. Nat. Mater. 12, 958–962 (2013).
Komarova, Y. & Malik, A. B. Annu. Rev. Physiol. 72, 463–493 (2010).
Fung, K. Y. Y., Fairn, G. D. & Lee, W. L. Traffic 19, 5–18 (2018).
Tuma, P. L. & Hubbard, A. L. Physiol. Rev. 83, 871–932 (2003).
Zhou, Q. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-019-0485-z (2019).
Ferrari, A. et al. Mol. Ther. 8, 284–294 (2003).
Nguyen, S. et al. mBio 8, e01874–01817 (2017).
Predescu, D., Predescu, S. & Malik, A. B. Proc. Natl Acad. Sci. USA 99, 13932–13937 (2002).
Ayloo, S. & Gu, C. Curr. Opin. Neurobiol. 57, 32–38 (2019).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jang, H.L., Sengupta, S. Transcellular transfer of nanomedicine. Nat. Nanotechnol. 14, 731–732 (2019). https://doi.org/10.1038/s41565-019-0494-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-019-0494-y
- Springer Nature Limited
This article is cited by
-
Thiol-mediated transportation pathway: an approach for improving tumor penetration of nanomedicines in vivo
Science China Chemistry (2024)
-
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Acta Pharmacologica Sinica (2020)